Risk and management of blood-borne infections in health care workers

Clinical Microbiology Reviews

Volumn 13, Issue 3, 2000, Pages 385-407

  Beltrami, Elise M ^a   Williams, Ian T ^b   Shapiro, Craig N ^b   Chamberland, Mary E ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; OCCUPATIONAL EXPOSURE; REVIEW; VIRUS TRANSMISSION;

BLOOD-BORNE PATHOGENS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; HEALTH PERSONNEL; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; RISK;

DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0033924255     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.13.3.385-407.2000     Document Type: Review

References (287)

1. Adams, K. S., C. L. Zehrer, and W. Thomas. 1993. Comparison of a needleless system with conventional heparin locks. Am. J. Infect. Control 21:263-269.
2. Agerton, T. B., F. J. Mahoney, L. B. Polish, and C. N. Shapiro. 1995. Impact of the bloodborne pathogens standard on vaccination of healthcare workers with hepatitis B vaccine. Infect. Control Hosp. Epidemiol. 16:287-291.
3. AIDS/TB Committee of the Society for Healthcare Epidemiology of America. 1997. Management of Healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. Infect. Control Hosp. Epidemiol. 18:349-363.
4. Alter, H. J., P. V. Holland, R. H. Purcell, J. J. Lander, S. M. Feinstone, A. G. Morrow, and P. J. Schmidt. 1972. Posttransfusion hepatitis after exclusion of commercial and hepatitis B antigen-positive donors. Ann. Intern. Med. 77:691-699.
5. Alter, H. J., L. B. Seeff, P. M. Kaplan, V. J. McAuliffe, E. C. Wright, J. L. Gerin, R. H. Purcell, P. V. Holland, and H. J. Zimmerman. 1976. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N. Engl. J. Med. 295:909-913.
6. Alter, M. J. 1993. The detection, transmission, and outcome of hepatitis C virus infection. Infect. Agents Dis. 2:155-166.
7. Alter, M. J. 1994. Occupational exposure to hepatitis C virus: a dilemma. Infect. Control Hosp. Epidemiol. 15:742-744.
8. Alter, M. J. 1994. Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C. Arch. Pathol. Lab. Med. 118:342-345.
9. Alter, M. J. 1995. Epidemiology of hepatitis C in the West. Semin. Liver Dis. 15:5-14.
10. Alter, M. J. 1997. The epidemiology of acute and chronic hepatitis C. Clin. Liver Dis. 1:559-568.
11. Alter, M. J., J. Ahtone, and J. E. Maynard. 1983. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit. Ann. Intern. Med. 99:330-333.
12. Alter, M. J., R. J. Gerety, L. Smallwood, R. E. Sampliner, E. Tabor, F. Deinhardt, G. Frosner, and G. M. Matanoski. 1982. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban United States population. J. Infect. Dis. 145:886-893.
13. Alter, M. J., D. Kruszon-Moran, D. V. Nainan, G. M. McQuillan, F. Gao, L. A. Moyer, R. A. Kaslow, and H. S. Margolis. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:556-562.
14. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, E. L. Meeks, and M. J. Beach for the Sentinel Counties Chronic Non-A Non-B Hepatitis Study Team. 1992. Natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 327:1899-1905.
15. Alter, M. J., and E. E. Mast. 1994. The epidemiology of viral hepatitis in the United States. Gastroenterol. Clin. N. Am. 23:437-455.
16. American College of Surgeons. 1999. Statement on the surgeon and hepatitis. Bull. Am. Coll. Surg. 84:21-24.
17. Anonymous. 1976. Relation of e antigen to infectivity of HBsAg-positive inoculations among medical personnel. Lancet ii:492-494.
18. Reference deleted.
19. Anonymous. 1996. New drugs for HIV infection. Med. Lett. Drugs Ther. 38:35-37.
20. Assogba, U., R. A. Ancelle Park, M. A. Rey, A. Barthelemy, J. Rottembourg, and J. C. Gluckman. 1988. Prospective study of HIV1 seropositive patients in hemodialysis centers. Clin. Nephrol. 29:312-314.
21. Beekman, S. E., D. Vlahow, D. E. Koziol, E. D. McShalley, and J. M. Schmitt. 1994. Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. Clin. Infect. Dis. 18:562-569.
22. Bell, D. M. 1991. Human immunodeficiency virus transmission in health care settings: risk and risk reduction. Am. J. Med. 91(Suppl. 3B):294-300.
23. Bell, D. M. 1997. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am. J. Med. 102(Suppl. 5B): 9-14.
24. Bell, D. M., C. N. Shapiro, C. Ciesielski, and M. E. Chamberland. 1995. Preventing bloodborne pathogen transmission from health-care workers to patients. Surg. Clin. N. Am. 75:1189-1203.
25. Bell, D. M., C. N. Shapiro, D. H. Culver, W. J. Martone, J. W. Curran, and J. M. Hughes. 1992. Risk of hepatitis B and human immunodeficiency virus transmission to a patient from an infected surgeon due to percutaneous injury during an invasive procedure: estimates based on a model. Infect. Agents Dis. 1:263-269.
26. Bennett, N. T., and R. J. Howard. 1994. Quantity of blood inoculated in a needlestick injury from suture needles. J. Am. Coll. Surg. 178:107-110.
27. Black, R. J. 1997. Animal studies of prophylaxis. Am. J. Med. 102(Suppl. 5B):39-44.
28. Blanchard, A., S. Ferris, S. Chamaret, D. Guétard, and L. Montagnier. 1998. Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients. J. Virol. 72:4537-4540.
29. Bond, W. W., M. S. Favero, N. J. Petersen, and J. W. Ebert. 1983. Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals. J. Clin. Microbiol. 18:535-538.
30. Bowden, F. J., B. Pollett, F. Birrell, and E. M. Dar. 1993. Occupational exposure to the human immunodeficiency virus and other bloodborne pathogens: a six year prospective study. Med. J. Aust. 158:810-812.
31. Boxall, E. H., and A. Ballard. 1997. Fifth of e antigen negative carriers of hepatitis B virus should not perform exposure prone procedures. Br. Med. J. 314:144.
32. Bradley, D. W., K. Krawczynski, M. J. Beach, and M. A. Purdy. 1991. Non-A, non-B hepatitis: toward the discovery of hepatitis C and E viruses. Semin. Liver Dis. 11:128-146.
33. Bukh, J., R. H. Miller, and R. H. Purcell. 1995. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin. Liver Dis. 15:41-63.
34. Busch, M. P., and G. A. Satten. 1997. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am. J. Med. 102(Suppl. 5B):117-124.
35. Callender, M. E., Y. S. White, and R. Williams. 1982. Hepatitis B virus infection in medical and health care personnel. Br. Med. J. 284:324-326.
36. Camma, C., P. Almasio, and A. Craxi. 1996. Interferon as treatment for acute hepatitis C: a meta-analysis. Dig. Dis. Sci. 41:1248-1255.
37. Reference deleted.
38. Cardo, D. M., K. G. Castro, J. A. Polder, and D. M. Bell. 1994. Management of occupational exposure to HIV, p. 361-375. In G. Schochetman and J. R. George (ed.), AIDS testing: a comprehensive guide to technical, medical, social, legal, and management issues, 2nd ed. Springer-Verlag, New York, N.Y.
39. Cardo, D. M., D. H. Culver, C. A. Ciesielski, P. U. Srivastava, R. Marcus, D. Abiteboul, J. Heptonstall, G. Ippolito, F. Lot, P. McKibben, D. M. Bell, and the Centers for Disease Control and Prevention Needlestick Surveillance Group. 1997. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N. Engl. J. Med. 337:1485-1490.
40. Carman, W. F. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J. Viral Hepatitis 4(Suppl. 1):11-20.
41. Carman, W. F., F. J. Van Deursen, L. T. Mimms, D. Hardie, R. Coppola, R. Decker, and R. Sanders. 1997. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 26:1658-1666.
42. Carpenter, C. C. J., M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. G. Montaner, D. D. Richman, M. S. Saag, R. T. Schooley, M. A. Thompson, S. Vella, P. G. Yeni, and P. A. Bolberding. 1998. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society - USA panel. JAMA 280:78-86.
43. Center for Disease Control. 1977. Hepatitis - control measures for hepatitis B in dialysis centers. HEW publication no. [CDC] 78-8358 (Viral Hepatitis Investigations and Control Series). Center for Disease Control, Atlanta, Ga.
44. Center for Disease Control. 1978. Lack of transmission of hepatitis B to humans after oral exposure to hepatitis B surface antigen-positive saliva. Morbid. Mortal. Weekly Rep. 27:247-248.
45. Centers for Disease Control. 1982. Recommendation of the Immunization Practices Advisory Committee (ACIP) - inactivated hepatitis B virus vaccine. Morbid. Mortal. Weekly Rep. 31:317-322, 328.
46. Centers for Disease Control. 1987. Recommendations for prevention of HIV transmission in health-care settings. Morbid. Mortal. Weekly Rep. 36(2S):1S-18S.
47. Centers for Disease Control. 1988. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. Morbid. Mortal. Weekly Rep. 37:377-382, 387-388.
48. Centers for Disease Control. 1989. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public safety workers. Morbid. Mortal. Weekly Rep. 38(Suppl. 6):1-37.
49. Centers for Disease Control. 1990. Possible transmission of human immunodeficiency virus to a patient during an invasive dental procedure. Morbid. Mortal. Weekly Rep. 39:489-493.
50. Centers for Disease Control. 1990. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. Morbid. Mortal. Weekly Rep. 39(RR-1):1-14.
51. Centers for Disease Control. 1991. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). Morbid. Mortal. Weekly Rep. 40(RR-13):1-25.
52. Centers for Disease Control. 1991. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. Morbid. Mortal. Weekly Rep. 40(RR-8):1-9.
53. Centers for Disease Control and Prevention. 1994. Zidovudine for the prevention of HIV transmission from mother to infant. Morbid. Mortal. Weekly Rep. 43:285-287.
54. Centers for Disease Control and Prevention. 1995. Hepatitis surveillance report, Atlanta, p. 3-6. Centers for Disease Control and Prevention, Atlanta, Ga.
55. Centers for Disease Control and Prevention. 1995. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994. Morbid. Mortal. Weekly Rep. 44:929-933.
56. Centers for Disease Control and Prevention. 1996. Outbreaks of hepatitis B virus infection among hemodialysis patients - California. Morbid. Mortal. Weekly Rep. 45:285-289.
57. Centers for Disease Control and Prevention. 1996. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. Morbid. Mortal. Weekly Rep. 45:467-472.
58. Centers for Disease Control and Prevention. 1997. Evaluation of blunt suture needles in preventing percutaneous injuries among health-care workers during gynecologic surgical procedures - New York City, March 1993-June 1994. Morbid. Mortal. Weekly Rep. 46:25-29.
59. Centers for Disease Control and Prevention. 1997. Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures - Minneapolis-St. Paul, New York City, and San Francisco, 1993-1995. Morbid. Mortal. Weekly Rep. 46:20-25.
60. Centers for Disease Control and Prevention. 1997. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infections Control Practices Advisory Committee (HICPAC). Morbid. Mortal. Weekly Rep. 46(RR-18):23.
61. Centers for Disease Control and Prevention. 1997. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus. Morbid. Mortal. Weekly Rep 46:603-606.
62. Centers for Disease Control and Prevention. 1998. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand, 1996-1998. Morbid. Mortal. Weekly Rep. 47:151-154.
63. Centers for Disease Control and Prevention. 1998. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Morbid. Mortal. Weekly Rep. 47(RR-7):1-34.
64. Centers for Disease Control and Prevention. 1998. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus. Morbid. Mortal. Weekly Rep. 47:603-606.
65. Centers for Disease Control and Prevention. 1998. Recommendations for the prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbid. Mortal. Weekly Rep. 47(RR-19):1-39.
66. Centers for Disease Control and Prevention. 1999. HIV/AIDS surveillance report, vol. 11, no. 1. Centers for Disease Control and Prevention, Atlanta, Ga.
67. Chamberland, M. E., L. R. Petersen, V. P. Munn, C. R. White, E. S. Johnson, M. P. Busch, A. J. Grindon, H. Kamel, P. M. Ness, A. W. Shafer, and G. Zeger. 1994. Human immune deficiency virus infection among health care workers who donate blood. Ann. Intern. Med. 121:269-273.
68. Chan, T. M., A. S. Lok, I. K. Cheng, and R. T. Chan. 1993. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 17:5-8.
69. Charache, P., J. L. Cameron, A. W. Maters, and E. I. Frantz. 1991. Prevalence of infection with human immunodeficiency virus in elective surgery patients. Ann. Surg. 214:562-568.
70. Reference deleted.
71. Cheynier, R., P. Langlade-Demoyen, M.-R. Marescot, S. Blanhe, G. Boudin, S. Wain-Hobson, C. Griscelli, E. Vilmer, and F. Plata. 1992. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22:2211-2217.
72. Chirgwin, K., T. K. S. Rao, and S. H. Landesman. 1989. HIV infection in a high prevalence hemodialysis unit. AIDS 3:731-735.
73. Ciesielski, C., D. Marianos, C.-Y. Ou, R. Dombaugh, J. Witte, R. Berkelman, B. Gooch, G. Myers, C.-C. Luo, G. Schochetman, J. Howell, A. Lasch, K. Bell, N. Economou, B. Scott, L. Furman, J. Curran, and H. Jaffe. 1992. Transmission of human immunodeficiency virus in a dental practice. Ann. Intern. Med. 116:798-805.
74. Ciesielski, C., and R. P. Metler. 1997. Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus. Am. J. Med. 102(Suppl. 5B):115-116.
75. Clerici, M., J. V. Giorgi, C.-C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, N. N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1012-1019.
76. Clerici, M., J. M. Levin, H. A. Kessler, A. Harris, J. A. Berzofsky, A. L. Linday, and G. M. Shearer. 1994. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 271: 42-46.
77. Cleveland, J. L., B. Gooch, and S. A. Lockwood. 1997. Occupational blood exposures in dentistry: a decade in review. Infect. Control Hosp. Epidemiol. 18:717-721.
78. Cleveland, J. L., S. A. Lockwood, B. F. Gooch, M. H. Mendelson, M. E. Chamberland, D. V. Valoui, S. L. Roistacher, J. M. Soloman, and D. W. Marianos. 1995. Percutaneous injuries in dentistry: an observational study. J. Am. Dent. Assoc. 126:745-751.
79. Cleveland, J. L., C. Siew, S. A. Lockwood, S. E. Gruninger, B. F. Gooch, and C. N. Shapiro. 1996. Hepatitis B vaccination and infection among U.S. dentists, 1983-1992. J. Am. Dent. Assoc. 127:1385-1390.
80. Collins, C. H., and D. A. Kennedy. 1987. Microbiological hazards of occupational needlestick and 'sharps' injuries. J. Appl. Bacteriol. 62:385-402.
81. Comodo, N., F. Martinelli, E. De Majo, M. G. Colao, M. A. DiPietro, F. Manescalchi, M. Salvadori, and E. Lanciotti. 1988. Risk of HIV infection on patients and staff of two dialysis centers: seroepidemiological findings and prevention trends. Eur. J. Epidemiol. 4:171-174.
82. Connor, E. M., R. S. Sperling, R. Gelber, P. Kiselev, G. Scott, M. J. O'Sullivan, R. VanDyke, M. Bey, W. Shearer, R. L. Jacobson, E. Jimenez, E. O'Neill, B. Bazin, J.-F. Delfraissy, M. Culnane, R. Coombs, M. Elkins, J. Moye, P. Stratton, J. Balsley, and the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331:1173-1180.
83. Cowan, D. N., J. F. Brundage, R. S. Pomerantz, R. N. Miller, and D. S. Burke. 1991. HIV infection among members of the US Army Reserve Components with medical and health occupations. JAMA 265:2826-2830.
84. Cuypers, H. T. M., D. Bresters, I. N. Winkel, H. W. Reesink, A. J. Weiner, M. Houghton, C. L. van der Poel, and P. N. Lelie. 1992. Storage conditions of blood samples and primer selection affect yield of cDNA polymerase chain reaction products of hepatitis C virus. J. Clin. Microbiol. 30:3320-3324.
85. Reference deleted.
86. Danila, R. N., K. L. MacDonald, F. S. Rhame, M. Moen, D. O. Reier, J. C. LeTourneau, M. K. Sheehan, J. Armstrong, M. E. Bender, M. T. Osterholm, and the Investigation Team. 1991. A look-back investigation of patients of an HIV-infected physician: public health implications. N. Engl. J. Med. 325:1406-1411.
87. Danzig, L. E., L. J. Short, K. Collins, M. Mahoney, S. Sepe, L. Bland, and W. R. Jarvis. 1995. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA 273:1862-1864.
88. Davis, G. L., J. Y. Lau, M. S. Urdea, P. D. Neuwald, J. C. Wilbur, and L. Corey. 1994. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 19:1337-1341.
89. Davis, G. L., and J. Y. N. Lau. 1995. Hepatitis C, p. 2082-2114. In W. S. Haubrich, F. Schaffner, and J. E. Berk (ed.), Gastroenterology, 5th ed. W. B. Saunders and Co., Philadelphia, Pa.
90. Denes, A. E., J. L. Smith, J. E. Maynard, I. L. Doto, K. R. Berquist, and A. J. Finkel. 1978. Hepatitis B infection in physicians: results of a nationwide seroepidemiologic survey. JAMA 239:210-212.
91. Reference deleted.
92. Di Bisceglie, A. M., G. M. Dusheiko, and M. C. Kew. 1985. Detection of markers of hepatitis B virus infection in urine of chronic carriers. J. Med. Virol. 16:337-341.
93. Dickinson, G. M., R. E. Morhart, N. G. Klimas, C. I. Bandea, J. M. Laracuvente, and A. L. Bisno. 1993. Absence of HIV transmission from an infected dentist to his patients: an epidemiologic and DNA sequence analysis. JAMA 269:1802-1806.
94. Dienstag, J. L., and D. M. Ryan. 1982. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am. J. Epidemiol. 115:26-39.
95. Donegan, S. P., K. A. Steger, L. Recla, R. S. Huff, B. G. Werner, P. A. Rice, and D. E. Craven. 1992. Seroprevalence of human immunodeficiency virus in parturients at Boston City Hospital: implications for public health and obstetric practice. Am. J. Obstet. Gynecol. 167:622-629.
96. Duckworth, G. J., J. Heptonstall, and C. Aitken. 1999. Transmission of hepatitis C virus from a surgeon to a patient. The Incident Control Team. Commun. Dis. Public Health 2:188-192.
97. Dusheiko, G. M., M. Smith, and P. J. Scheuer. 1990. Hepatitis C virus transmitted by human bite. Lancet 336:503-504.
98. Reference deleted.
99. Elmslie, K., M. Ricketts, and L. Mulligan. 1990. Guidelines for counseling persons who have had an occupational exposure to human immunodeficiency virus. Can. Dis. Weekly Rep. 19(Suppl. 2):1-3.
100. Erice, A., D. L. Mayers, D. G. Strike, K. J. Sannerud, F. E. McCutchan, K. Henry, and H. H. Balfour, Jr. 1993. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N. Engl. J. Med. 328:1163-1165.
101. Eron, J. J., S. L. Benoit, J. Jemsek, R. D. MacArthur, J. Santana, J. B. Quinn, D. R. Kuritzkes, M. A. Fallon, and M. Rubin. 1995. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. N. Engl. J. Med. 333:1662-1669.
102. Esteban, J. I., J. Gomez, M. Martell, B. Cabot, J. Quer, J. Camps, A. Gonzales, T. Otero, A. Moya, R. Estaban, and J. Guardia. 1996. Transmission of hepatitis C virus by a cardiac surgeon. N. Engl. J. Med. 334:555-560.
103. Fahey, B. J., D. E. Koziol, S. M. Banks, and D. K. Henderson. 1991. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am. J. Med. 90:145-153.
104. Farci, P., H. J. Alter, D. Wong, R. H. Miller, J. W. Shih, B. Jett, and R. H. Purcell. 1991. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N. Engl. J. Med. 325:98-104.
105. Favero, M. S. 1985. Sterilization, disinfection, and antisepsis in the hospital, p. 129-137. In E. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
106. Favero, M. S., and W. W. Bond. 1993. Disinfection and sterilization, p. 565-575. In A. J. Zuckerman and H. C. Thomas (ed.), Viral hepatitis: scientific basis and clinical management. Churchill Livingston, New York, N.Y.
107. Feinman, S. V., B. Berris, A. Rebane, J. C. Sinclair, S. Wilson, and D. Wrobel. 1979. Failure to detect hepatitis B surface antigen (HBsAg) in feces of HBsAg-positive persons. J. Infect. Dis. 140:407-410.
108. Flynn, N. M., S. M. Pollet, J. R. Van Horne, R. Elvebakk, S. D. Harper, and J. R. Carlson. 1987. Absence of HIV antibody among dental professionals exposed to infected patients. West. J. Med. 146:439-442.
109. Reference deleted.
110. Fried, M. W., and J. H. Hoofnagle. 1995. Therapy of hepatitis C. Semin. Liver Dis. 15:82-91.
111. Fujiyama, S., S. Kawano, S. Sato, M. Tanaka, M. Goto, Y. Taura, T. Sato, T. Kawahara, and K. Mizuno. 1992. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. Hepatogastroenterology 39:161-165.
112. Garner, J. S., and the Hospital Infection Control Practices Advisory Committee. 1996. Guideline for isolation precautions in hospitals. Infect. Control Hosp. Epidemiol. 17:53-80.
113. Gartner, K. 1992. Impact of a needleless intravenous system in a university hospital. Am. J. Infect. Control 20:75-79.
114. Gerberding, J. L. 1994. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J. Infect. Dis. 170:1410-1417.
115. Gerberding, J. L. 1995. Management of occupational exposures to bloodborne viruses. N. Engl. J. Med. 332:444-451.
116. Gerberding, J. L., and D. K. Henderson. 1992. Management of occupational exposures to bloodborne pathogens: hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. Clin. Infect. Dis. 14:1179-1185.
117. Gerberding, J. L., C. Littell, A. Tarkington, A. Brown, and W. P. Schecter. 1990. Risk of exposure of surgical personnel to patients' blood during surgery at San Francisco General Hospital. N. Engl. J. Med. 322:1788-1793.
118. Gershon, R. R. M., D. Vlahov, H. Farzedegan, and M. J. Alter. 1995. Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. Infect. Control Hosp. Epidemiol. 16:194-197.
119. Goldman, M., C. Leisnard, J.-L. Vanherweghem, N. Dolle, C. Toussaint, S. Sprecher, J. Cogniaux, and L. Thiry. 1986. Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Br. Med. J. 293:161-162.
120. Gordin, F. M., C. Gilbert, H. P. Hawley, and A. Willoughby. 1990. Prevalence of human immunodeficiency virus and hepatitis B virus in unselected hospital admissions: implications for mandatory testing and universal precautions. J. Infect. Dis. 161:14-17.
121. Grady, G. F., V. A. Lee, A. M. Prince, G. L. Gitnick, K. A. Fawaz, G. N. Vyas, M. D. Levitt, J. R. Senior, J. T. Galambos, T. E. Bynum, J. W. Singleton, B. F. Clowdus, K. Akdamar, R. D. Aach, E. I. Winkelman, G. M. Schiff, and T. Hersh. 1978. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J. Infect. Dis. 138:625-638.
122. Gretch, D. R. 1997. Diagnostic tests for hepatitis C. Hepatology 26(Suppl. 1):43S-47S.
123. Gretch, D. R., C. dela Rosa, R. L. Carithers, R. A. Wilson, K. Lindsay, R. P. Perrillo, and J. Albrecht. 1995. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann. Intern. Med. 123:321-329.
124. Gruninger, S. E., C. Siew, S.-B. Chang, R. Clayton, J. K. Leete, S. A. Hojvat, A. C. Verrusio, and E. A. Neidle. 1992. Human immunodeficiency virus type 1 infection among dentists. J. Am. Dent. Assoc. 123:57-64.
125. Guptan, R. C., V. Thakur, S. K. Sarin, K. Banerjee, and P. Khandekar. 1996. Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am. J. Gastroenterol. 91:1312-1317.
126. Hadler, S. C., I. L. Doto, J. E. Maynard, J. Smith, B. Clark, J. Masley, T. Eikhoff, C. K. Himmelsbach, and W. R. Cole. 1985. Occupational risk of hepatitis B infection in hospital workers. Infect. Control 6:24-31.
127. Haiduven, D. J., T. M. Demaio, and D. A. Stevens. 1992. A five-year study of needlestick injuries: significant reduction associated with communication, education, and convenient placement of sharps containers. Infect. Control Hosp. Epidemiol. 13:265-271.
128. Halle, M. 1996. Patients want ban on operations by doctors with hepatitis B. Br. Med. J. 313:576.
129. Halle, M. 1996. Surgeon had mutant form of hepatitis B. Br. Med. J. 313:771.
130. Hamory, B. H. 1983. Underreporting of needlestick injuries in a university hospital. Am. J. Infect. Control 11:174-177.
131. Hansen, M. E., G. L. Miller III, H. Redman, and D. D. McIntire. 1993. Needle-stick injuries and blood contacts during invasive radiologie procedures: frequency and risk factors. Am. J. Roentgenol. 160:1119-1122.
132. Hardy, N. M., S. Sandroni, S. Danielson, and W. J. Wilson. 1992. Antibody to hepatitis C virus increases with time on hemodialysis. Clin. Nephrol. 38:44-48.
133. Harpaz, R., L. Von Seidlein, F. M. Averhoff, M. P. Tormey, S. D. Sinha, K. Kotsopoulou, S. B. Lambert, B. H. Robertson, J. D. Cherry, and C. N. Shapiro. 1996. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N. Engl. J. Med. 334:549-554.
134. Harris, J. R., R. F. Finger, J. M. Kobayashi, S. C. Hadler, B. L. Murphy, R. L. Berkelman, and K. E. Russell. 1984. The low risk of hepatitis B in rural hospitals: results of an epidemiologic survey. JAMA 252:3270-3272.
135. Hayashi, J., K. Nakashima, W. Kajiyama, A. Noguchi, M. Morofuji, Y. Maeda, and S. Kashiwaji. 1991. Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am. J. Epidemiol. 134:651-657.
136. Henderson, D. K. 1991. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus type 1: current status and prospects for the future. Am. J. Med. 91(Suppl. 3B):312S-319S.
137. Henderson, D. K., and J. L. Gerberding. 1989. Prophylactic zidovudine after occupational exposure to human immunodeficiency virus: an interim analysis. J. Infect. Dis. 160:321-327.
138. Heptonstall, J. 1991. Outbreaks of hepatitis B virus infection associated with infected surgical staff. Dis. Rep. CDR Rev. 1:R81-R85.
139. Heptonstall, J. 1996. Lessons from two linked clusters of acute hepatitis B in cardiothoracic surgery patients. Dis. Rep. CDR Rev. 6:R119-R125.
140. Reference deleted.
141. Hernandez, M. E., M. Bruguera, T. Puyuelo, J. M. Barrera, J. M. Sanchez-Tapias, and J. Rodes. 1992. Risk of needlestick injuries in the transmission of hepatitis C virus in hospital personnel. J. Hepatol. 16:56-58.
142. Ho, D. D., T. Moudgil, and M. Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321:1621-1625.
143. Hoofnagle, J. H. 1995. Hepatitis B, p. 2062-2063. In W. S. Haubrich, F. Schaffner, and J. E. Berk (ed.), Gastroenterology, 5th ed. W. B. Saunders and Co., Philadelphia, Pa.
144. Hoofnagle, J. H., and A. M. Di Bisceglie. 1991. Serologic diagnosis of acute and chronic viral hepatitis. Semin. Liver Dis. 11:73-83.
145. Hsu, H. H., T. L. Wright, D. Luba, M. Martin, S. M. Feinstone, G. Garcia, and H. B. Greenberg. 1991. Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology 14:763-767.
146. Incident Investigation Team et al. 1997. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N. Engl. J. Med. 336:178-184.
147. Reference deleted.
148. Ippolito, G., V. Puro, G. De Carli, and the Italian Study Group on Occupational Risk of HIV Infection. 1993. The risk of occupational human immunodeficiency virus infections in health care workers. Arch. Intern. Med. 153:1451-1458.
149. Reference deleted.
150. Irwin, G. R., A. M. Allen, W. H. Bancroft, J. J. Karwacki, H. L. Brown, R. H. Pinkerton, M. Wilhight, and F. H. Top, Jr. 1975. Hepatitis B antigen in saliva, urine, and stool. Infect. Immun. 11:142-145.
151. Jaffe, H. W., J. M. McCurdy, M. L. Kalish, T. Liberti, G. Metellus, B. H. Bowman, S. B. Richards, A. R. Neasman, and J. J. Witte. 1994. Lack of HIV transmission in the practice of a dentist with AIDS. Ann. Intern. Med. 121:855-859.
152. Jagger, J., E. H. Hunt, J. Brand-Elnagger, and R. D. Pearson. 1988. Rates of needle-stick injury caused by various devices in a university hospital. N. Engl. J. Med. 319:284-288.
153. Jagger, J., E. H. Hunt, and R. D. Pearson. 1990. Sharp object injuries in the hospital: causes and strategies for prevention. Am. J. Infect. Control 18: 227-231.
154. Janssen, R. S., M. E. St. Louis, G. A. Satten, S. E. Critchley, L. R. Petersen, R. S. Stafford, J. W. Ward, D. L. Hanson, N. Olivio, C. A. Schable, T. J. Dondero, and the Hospital HIV Surveillance Group. 1992. HIV infection among patients in U.S. acute care hospitals: strategies for the counseling and testing of hospital patients. N. Engl. J. Med. 327:445-452.
155. Jenison, S. A., S. M. Lemon, L. N. Baker, and J. E. Newbold. 1987. Quantitative analysis of hepatitis B virus DNA in saliva and semen of chronically infected homosexual men. J. Infect. Dis. 156:299-307.
156. Reference deleted.
157. Jochimsen, E. M. 1997. Failures of zidovudine post-exposure prophylaxis. Am. J. Med. 102(Suppl. 5B):52-55.
158. Kelen, G. D., T. DiGiovanna, L. Bisson, D. Kalainov, K. T. Sivertson, and T. C. Quinn. 1989. Human immunodeficiency virus infection in emergency department patients: epidemiology, clinical presentations, and risk to health care workers, the Johns Hopkins experience. JAMA 262:516-522.
159. Kelen, G. D., S. Fritz, B. Qaqish, R. Brookmeyer, J. L. Baker, R. L. Kline, R. M. Cuddy, T. K. Goessel, D. Floccare, K. A. Williams, K. T. Sivertson, S. Altman, and T. C. Quinn. 1988. Unrecognized human immunodeficiency virus infection in emergency department patients. N. Engl. J. Med. 318: 1645-1650.
160. Kelen, G. D., G. B. Green, R. H. Purcell, D. W. Chan, B. F. Qaqish, K. T. Sivertson, and T. C. Quinn. 1992. Hepatitis B and hepatitis C in emergency department patients. N. Engl. J. Med. 326:1399-1404.
161. Kelker, H. C., M. Seidlin, M. Vogler, and F. T. Valentine. 1992. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. AIDS 8:1355-1359.
162. Kiyosawa, K., T. Sodeyama, E. Tanaka, Y. Nakano, S. Furuta, K. Nishioka, R. H. Purcell, and H. J. Alter. 1991 Hepatitis C in hospital employees with needlestick injuries. Ann. Intern. Med. 115:367-369.
163. Klein, R. S., K. Freeman, P. E. Taylor, and C. E. Stevens. 1991. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 339:1539-1542.
164. Klein, R. S., J. A. Phelan, K. Freeman, C. Schable, G. H. Friedland, N. Trieger, and N. H. Steigbigel. 1988. Low occupational risk of human immunodeficiency virus infection among dental professionals. N. Engl. J. Med. 318:86-90.
165. Knodell, R. G., M. E. Conrad, A. L. Ginsberg, and C. J. Bell. 1976. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Lancet i:557-561.
166. Kobayashi, H., M. Tsuzuki, K. Koshimizu, H. Toyama, N. Yoshihara, T. Shikata, K. Abe, K. Mizuno, N. Otomo, and T. Oda. 1984. Susceptibility of hepatitis B virus to disinfectants and heat. J. Clin. Microbiol. 20:214-216.
167. Koretz, R. L., M. Brezina, A. J. Polito, S. Quan, J. Wilbur, R. Dinello, and G. Gitnick. 1993. Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis. Hepatology 17:361-365.
168. Reference deleted.
169. Krawczynski, K., M. J. Alter, and D. L. Tankersley. 1996. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J. Infect. Dis. 173:822-828.
170. Reference deleted.
171. Langlade-Demoyen, P., N. Ngo-Giang-Huong, F. Ferchal, and E. Oksenhendler. 1994. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contacts of HIV-infected patients. J. Clin. Investig. 93:1293-1297.
172. Laras, A., J. Koskinas, K. Avgidis, and S. J. Hadziyannis. 1998. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients. J. Viral Hepatitis 5:241-248.
173. Lau, J. Y., M. Mizokami, J. A. Kolberg, G. L. Davis, L. E. Prescott, T. Ohno, R. P. Perrillo, K. L. Lindsay, R. G. Gish, K.-P. Qian, M. Kohara, P. Simmonds, and M. S. Urdea. 1995. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J. Infect. Dis. 171:281-289.
174. Liang, T. J., K. Hasegawa, S. J. Munoz, C. N. Shapiro, B. Yoffe, B. J. McMahon, C. Feng, H. Bei, M. J. Alter, and J. L. Dienstag. 1994. Hepatitis B virus precore mutation and fulminant hepatitis in the United States: a polymerase chain reaction-based assay for the detection of specific mutation. J. Clin. Investig. 93:550-555.
175. Lot, F., and D. Abiteboul. 1995. Health-care workers infected with HIV in France as of June 30, 1995. Bull. Epidemiol. Hebd. 44:193-194.
176. Louie, M., D. E. Low, and S. V. Feinman. 1992. Prevalence of bloodborne infective agents among people admitted to a Canadian hospital. Can. Med. Assoc. J. 146:1331-1334.
177. Mahoney, F. J., K. Stewart, H. Hu, P. Coleman, and M. Alter. 1997. Progress toward elimination of hepatitis B virus transmission among health care workers in the United States. Arch. Intern. Med. 157:2601-2605.
178. Mangione, C. M., J. L. Gerberding, and S. R. Cumings. 1991. Occupational exposure to HIV: frequency and rates of underreporting of percutaneous and mucocutaneous exposures by medical housestaff. Am. J. Med. 90:85-90.
179. Marcus, R., D. H. Culver, D. M. Bell, P. U. Srivastava, M. H. Mendelson, R. J. Zalenski, B. Farber, D. Fligner, J. Hassett, T. C. Quinn, C. A. Schable, E. P. Sloan, P. Tsui, and G. D. Kelen. 1993. Risk of human immunodeficiency virus infection among emergency department workers. Am. J. Med. 94:363-369.
180. Reference deleted.
181. Martin, M. A., M. Reichelderfer, and the Association for Professionals in Infection Control and Epidemiology, Inc. 1994. APIC guideline for infection prevention and control in flexible endoscopy. Am. J. Infect. Control 22:19-38.
182. Mast, E. E., and M. J. Alter. 1993. Prevention of hepatitis B virus infection among health-care workers, p. 295-307. In R. W. Ellis (ed.), Hepatitis B vaccines in clinical practice. Marcel Dekker, Inc., New York, N.Y.
183. Mast, S. T., J. D. Woolwine, and J. L. Gerberding. 1992. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J. Infect. Dis. 168:1589-1592.
184. McGeer, A., A. E. Simor, and D. E. Low. 1990. Epidemiology of needlestick injuries in house officers. J. Infect. Dis. 162:961-964.
185. Reference deleted.
186. Mishu, B., W. Schaffner, J. M. Horan, L. H. Wood, R. H. Hutcheson, and P. C. McNabb. 1990. A surgeon with AIDS: lack of evidence of transmission to patients. JAMA 264:467-470.
187. Mitsui, T., K. Iwano, K. Masuko, C. Yamazaki, H. Yakamoto, F. Tsuda, T. Tanaka, and S. Mishiro. 1992. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 16:1109-1114.
188. Montecalvo, M. A., M. S. Lee, H. DePalma, P. S. Wynn, A. B. Lowenfels, U. Jorde, D. Wuest, A. Klingamen, T. A. O'Brien, M. Calmann, and G. P. Wormser. 1995. Seroprevalence of human immunodeficiency virus-1, hepatitis B virus, and hepatitis C virus in patients having major surgery. Infect. Control Hosp. Epidemiol. 16:627-632.
189. Moyer, L. A., and M. J. Alter. 1994. Hepatitis C virus in the hemodialysis setting: a review with recommendations for control. Semin. Dialysis 7:124-127.
190. Moyer, L. A., M. J. Alter, and M. S. Favero. 1990. Hemodialysis-associated hepatitis B: revised recommendations for serologic screening. Semin. Dialysis 3:201-204.
191. Mullins, J. R., and P. B. Harrison. 1993. The questionable utility of mandatory screening for the human immunodeficiency virus. Am. J. Surg. 166: 676-679.
192. Nagachinta, T., C. R. Gold, F. Cheng, P. N. R. Heseltine, and P. R. Kerndt. 1996. Unrecognized HIV-1 infection in inner-city emergency department patients. Infect. Control Hosp. Epidemiol. 17:174-177.
193. Nakano, Y., K. Kiyosawa, T. Sodeyama, E. Tanaka, A. Matsumoto, T. Ichijo, M. Mizokami, and S. Furuta. 1995. Acute hepatitis C transmitted by needlestick accident despite short duration interferon treatment. J. Gastroenterol. Hepatol. 10:609-611.
194. Reference deleted.
195. Natov, S. N., and B. J. Pereira. 1996. Hepatitis C in dialysis patients. Adv. Renal Replace. Ther. 3:275-283.
196. Neal, K. R., J. Dornan, and W. L. Irving. 1997. Prevalence of hepatitis C antibodies among healthcare workers of two teaching hospitals: who is at risk? Br. Med. J. 314:179-180.
197. Neal, K. R., D. A. Jones, D. Killey, and V. James. 1994. Risk factors for hepatitis C virus infection: a case-control study of blood donors in the Trent Region (UK). Epidemiol. Infect. 112:595-601.
198. Niitsuma, H., M. Ishii, Y. Saito, M. Miura, K. Kobayashi, H. Ohori, and T. Toyota. 1995. Prevalence of precore-defective mutant of hepatitis B virus in HBV carriers. J. Med. Virol. 46:397-402.
199. Niu, M. T., L. T. Penberthy, M. J. Alter, C. W. Armstrong, G. B. Miller, and S. C. Hadler. 1989. Hemodialysis-associated hepatitis B: report of an outbreak. Dialysis Transplant. 18:542-545.
200. Niu, M. T., D. S. Stein, and S. M. Schnittmann. 1993. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment interventions in humans and animal retrovirus infections. J. Infect. Dis. 168:1490-1501.
201. Noguchi, S., M. Sata, H. Suzuki, K. Ohba, M. Mizokami, and K. Tanikawa. 1997. Early therapy with interferon for acute hepatitis C acquired through a needlestick. Clin. Infect. Dis. 24:992-994.
202. Noone, P. A., I. S. Symington, and W. F. Carman. 1997. Hepatitis B and health care workers. Lancet 350:219.
203. Noskin, G. A. 1995. Prevention, diagnosis, and management of viral hepatitis: a guide for primary care physicians. American Medical Association, Division of Health Science, Chicago, Ill.
204. O'Briain, D. S. 1991. Patterns of occupational hand injury in pathology: the interaction of blades, needles, and the dissector's digits. Arch. Pathol. Lab. Med. 115:610-613.
205. Oguchi, H., M. Miyasaka, S. Tokunaga, K. Hora, S. Ichikawa, T. Ochi, K. Yamada, M. Nagasawa, Y. Kanno, T. Azizawa, et al. 1992. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin. Nephrol. 38:36-43.
206. O'Neill, T. M., A. V. Abbott, and S. E. Radecki. 1992. Risk of needlesticks and occupational exposures among residents and medical students. Arch. Intern. Med. 152:1451-1456.
207. Osborn, E. H. S., M. A. Papadakis, and J. L. Gerberding. 1999. Occupational exposures to body fluids among medical students: a seven-year longitudinal study. Ann. Intern. Med. 130:45-51.
208. Ou, C.-Y., C. A. Ciesielski, G. Myers, C. I. Bandea, C.-C. Luo, B. T. M. Korber, J. I. Mullins, G. Schochetman, R. L. Berkelman, A. N. Economou, J. J. Witte, L. J. Furman, G. A. Satten, K. A. MacInnes, J. W. Curran, H. W. Jaffe, Laboratory Investigation Group, and Epidemiologic Investigation Group. 1992. Molecular epidemiology of HIV transmission in a dental practice. Science 256:1165-1171.
209. Owens, D. K., M. Holodniy, A. M. Garber, J. Scott, S. Sonnad, L. Moses, B. Kinosian, and J. S. Schwartz. 1996. Polymerase chain reaction for the diagnosis of HIV infection in adults: a meta-analysis with recommendations for clinical practice and study design. Ann. Intern. Med. 124:803-815.
210. Panlilio, A. L., D. R. Foy, J. R. Edwards, D. M. Bell, B. A. Welch, C. M. Parrish, D. H. Culver, P. W. Lowry, W. R. Jarvis, and C. A. Perlino. 1991. Blood contacts during surgical procedures. JAMA 265:1533-1537.
211. Panlilio, A. L., C. N. Shapiro, C. A. Schable, M. H. Mendelson, M. A. Montecalvo, L. M. Kunches, S. W. Perry III, J. R. Edwards, P. U. Srivastava, D. H. Culver, I. B. Weisfuse, V. Jorde, J. M. Davis, J. Solomon, G. P. Wormser, J. Ryan, D. M. Bell, M. E. Chamberland, and the Serosurvey Study Group. 1995. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. J. Am. Coll. Surg. 180:16-24.
212. Panlilio, A. L., B. A. Welch, D. M. Bell, D. R. Foy, C. M. Parrish, C. A. Perlino, and L. Klein. 1992. Blood and amniotic fluid contact sustained by obstetric personnel during deliveries. Am. J. Obstet. Gynecol. 167:703-708.
213. Pattison, C. P., K. M. Boyer, J. E. Maynard, and P. C. Kelly. 1974. Epidemic hepatitis in a clinical laboratory: possible association with computer card handling. JAMA 230:854-857.
214. Pawlotsky, J.-M. 1997. Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology 26:1-4.
215. Pereira, B. J., and A. S. Levey. 1997. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int. 51:981-999.
216. Reference deleted.
217. Peterman, T. A., G. R. Lang, N. J. Mikos, S. L. Solomon, C. A. Schable, P. M. Feorino, J. A. Britz, and J. R. Allen. 1986. HTLV-III/LAV infection in hemodialysis patients. JAMA 255:2324-2326.
218. Peters, M., G. L. Davis, J. S. Dooley, and J. H. Hoofnagle. 1986. The interferon system in acute and chronic viral hepatitis. Prog. Liver Dis. 8:453-467.
219. Polakoff, S. 1986. Acute hepatitis B in patients in Britain related to previous operations and dental treatment. Br. Med. J. Clin. Res. 293:33-36.
220. Polakoff, S. 1986. Acute viral hepatitis B: laboratory reports 1980-4. Br. Med. J. Clin. Res. 293:37-38.
221. Polish, L. B., M. J. Tong, R. L. Co, P. J. Coleman, and M. J. Alter. 1993. Risk factors for hepatitis C virus infection among healthcare personnel in a community hospital. Am. J. Infect. Control 21:196-200.
222. Popejoy, S. L., and D. E. Fry. 1991. Blood contact and exposure in the operating room. Surg. Gynecol. Obstet. 172:480-483.
223. Prentice, M. B. 1992. Infection with hepatitis B virus after open heart surgery. Br. Med. J. 304:761-764.
224. Prince, A. M. 1994. Challenges for development of hepatitis C virus vaccines. FEMS Microbiol. Rev. 14:273-277.
225. Puro, V., N. Petrosillo, and G. Ippolito. 1995. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am. J. Infect. Control 23:273-277.
226. Quebbeman, E. J., G. L. Telford, S. Hubbard, K. Wadsworth, B. Hardman, H. Goodman, and M. S. Gottlieb. 1991. Risk of blood contamination and injury to operating room personnel. Ann. Surg. 214:614-620.
227. Ranki, A., S. Mattinen, R. Yarchoan, S. Broder, J. Ghrayeb, J. Lehdevirta, and K. Krohn. 1989. T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. AIDS 3:63-69.
228. Ridzon, R., K. Gallagher, C. Ciesielski, M. B. Ginsberg, B. J. Robertson, C.-C. Luo, and A. DeMana, Jr. 1997. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N. Engl. J. Med. 336:919-922.
229. Robert, L. M., M. E. Chamberland, J. L. Cleveland, R. Marcus, B. F. Gooch, P. U. Srivastava, D. H. Culver, H. W. Jaffe, D. W. Marianos, A. L. Panlilio, and D. M. Bell. 1995. Investigations of patients of health care workers infected with HIV: the Centers for Disease Control and Prevention database. Ann. Intern. Med. 122:653-657.
230. Rogers, A. S., J. W. Froggatt III, T. Townsend, T. Gordon, A. J. L. Brown, E. C. Holmes, L. A. Zhang, and H. Moses III. 1993. Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA 269:1795-1801.
231. Roth, W. K., J.-H. Lee, B. Ruster, and S. Zeuzem. 1996. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J. Clin. Microbiol. 34:261-264.
232. Ruprecht, R. M., L. G. O'Brien, L. D. Rossoni, and S. Nusinoff-Lehrman. 1986. Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidine. Nature 323:467-469.
233. Sanchez-Quijano, A., J. A. Pineda, E. Lissen, M. Leal, M. A. Diaz-Torres, F. Garcia de Pesquera, F. Rivera, R. Castro, and J. Munoz. 1988. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet i:1245-1249.
234. Satori, M., G. La Terra, M. Aglietta, A. Manzin, C. Navino, and G. Verzetti. 1993. Transmission of hepatitis C via blood splash into conjunctiva. Scand. J. Infect. Dis. 25:270-271.
235. Sattar, S. A., and V. S. Springthorpe. 1991. Survival and disinfectant inactivation of the human immunodeficiency virus. Rev. Infect. Dis. 13:430-447.
236. Schlipkoter, U., M. Roggendorf, K. Cholmakow, A. Weise, and F. Deinhardt. 1990. Transmission of hepatitis C virus (HCV) from a haemodialysis patient to a medical staff member. Scand. J. Infect. Dis. 22:757-758.
237. Reference deleted.
238. Schneiderman, L. J., and R. M. Kaplan. 1992. Fear of dying and HIV infection vs hepatitis B infection. Am. J. Infect. Control 82:584-586.
239. Reference deleted.
240. Seeff, L. B., H. J. Zimmerman, E. C. Wright, J. D. Finkelstein, P. Garcia-Pont, H. B. Greenlee, A. A. Dietz, C. M. Leevy, C. H. Tamburro, E. R. Schiff, R. Zemel, D. S. Zimmon, and R. W. McCollom. 1977. A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis: a Veterans Administration cooperative study. Gastroenterology 72:111-121.
241. Segal, H. E., C. H. Llewellyn, G. Irwin, W. H. Bancroft, G. P. Boe, and D. J. Balaban. 1976. Hepatitis B antigen and antibody in the US Army: prevalence in health care personnel. Am. J. Public Health 66:667-671.
242. Selgas, R., R. Martinez-Zapico, M. A. Bajo, J. R. Romero, J. Munoz, C. Rinon, B. Miranda, and J. L. Miguel. 1992. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Perit. Dial. Int. 12:28-30.
243. Shapiro, C. N., J. I. Tokars, and M. E. Chamberland. 1996. Use of the hepatitis B vaccine and infection with hepatitis B and C among orthopaedic surgeons. J. Bone Joint Surg. 78:1791-1800.
244. Shih, C.-C., H. Kaneshima, L. Rabin, R. Namikawa, P. Sager, J. McGowan, and J. M. McCune. 1991. Postexposure prophylaxis with zidovudine suppressed human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J. Infect. Dis. 163:625-627.
245. Shikata, T., T. Karasawa, K. Abe, T. Uzawa, H. Suzuki, T. Oda, M. Imai, M. Mayumi, and Y. Moritsugu. 1977. Hepatitis B antigen and infectivity of hepatitis B virus. J. Infect. Dis. 136:571-576.
246. Reference deleted.
247. Reference deleted.
248. Smith, J. L., J. E. Maynard, K. R. Berquist, I. L. Doto, H. M. Webster, and M. J. Sheller. 1976. Comparative risk of hepatitis B among physicians and dentists. J. Infect. Dis. 133:705-706.
249. Sodeyama, T., K. Kiyosawa, and A. Urushihara. 1993. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. Arch. Intern. Med. 153:1565-1572.
250. Sperling, R. S., D. E. Shapiro, R. W. Coombs, J. A. Todd, S. A. Herman, G. D. McSherry, M. J. O'Sullivan, R. B. VanDyke, E. Jiminez, C. Rouzioux, P. M. Flynn, and J. L. Sullivan. 1996. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N. Engl. J. Med. 335:1621-1629.
251. Struve, J., B. Aronsson, B. Frenning, M. Forsgren, and O. Weiland. 1994. Prevalence of antibodies against hepatitis C virus infection among health-care workers in Stockholm. Scand. J. Gastroenterol. 29:360-362.
252. Sundkvist, T., G. R. Hamilton, D. Rimmer, B. G. Evans, and C. G. Teo. 1998. Fatal outcome of transmission of hepatitis B from an e antigen negative surgeon. Commun. Dis. Public Health 1:48-50.
253. Tavares, L., C. Roneker, K. Johnston, S. N. Lehrman, and F. de Noronha. 1987. 3′-Azido-3′-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS. Cancer Res. 47:3190-3194.
254. Terrell, F., and B. Williams. 1993. Implementation of a customized needleless intravenous delivery system. J. Intraven. Nurs. 16:339-344.
255. Thomas, D. L., S. E. Gruninger, C. Siew, E. D. Joy, and T. C. Quinn. 1996. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am. J. Med. 100:41-45.
256. Tokars, J. I., M. J. Alter, and M. S. Favero. 1995. National surveillance of dialysis-associated diseases in the United States, 1993. Centers for Disease Control and Prevention, Atlanta, Ga.
257. Tokars, J. I., M. J. Alter, M. S. Favero, L. A. Moyer, E. Miller, and L. A. Bland. 1994. National surveillance of dialysis associated diseases in the United States, 1992. ASAIO J. 40:1020-1031.
258. Tokars, J. I., D. M. Bell, D. H. Culver, R. Marcus, M. H. Mendelson, E. P. Sloan, B. F. Farber, D. Fligner, M. E. Chamberland, P. S. McKibben, and W. J. Martone. 1992. Percutaneous injuries during surgical procedures. JAMA 267:2899-2904.
259. Reference deleted.
260. Tokars, J. I., M. E. Chamberland, C. A. Schable, D. H. Culver, M. Jones, P. S. McKibben, D. M. Bell, and the American Academy of Orthopaedic Surgeons Serosurvey Study Committee. 1992. A survey of occupational blood contact and HIV infection among orthopedic surgeons. JAMA 268: 489-494.
261. Tokars, J. I., D. H. Culver, M. H. Mendelson, E. P. Sloan, B. F. Farber, D. J. Fligner, M. E. Chamberland, R. Marcus, P. S. McKibben, and D. M. Bell. 1995. Skin and mucous membrane contacts with blood during surgical procedures: risk and prevention. Infect. Control Hosp. Epidemiol. 16:703-711.
262. Tong, S., and C. Trepo. 1997. The HBe-minus mutants of hepatitis B virus, p. 89-104. In T. J. Harrison and A. J. Zuckerman (ed.), The molecular medicine of viral hepatitis. John Wiley and Sons, Ltd., Chichester, United Kingdom.
263. Trepka, M. J., A. J. Davidson, and J. M. Douglas, Jr. 1996. Extent of undiagnosed HIV infection in hospitalized patients: assessment by linkage of seroprevalence and surveillance methods. Am. J. Prev. Med. 12:195-202.
264. Tsai, C.-C., K. E. Follis, A. Sabo, T. W. Beck, R. F. Grant, N. Bischofberger, R. E. Benveniste, and R. Black. 1995. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxyprophyl) adenosine. Nature 270:1197-1199.
265. Tsude, K., S. Fujiyama, S. Sato, S. Kawano, Y. Taura, K. Yoshida, and T. Sato. 1992. Two cases of accidental transmission of hepatitis C to medical staff. Hepatogastroenterology 39:73-75.
266. Turner, S. B., L. M. Kunches, K. F. Gordon, P. H. Travers, and N. E. Mueller. 1989. Occupational exposure to human immunodeficiency virus (HIV) and hepatitis B virus (HBV) among embalmers: a pilot seroprevalence study. Am. J. Public Health 79:1425-1426.
267. Reference deleted.
268. U.S. Department of Labor Occupation Safety and Health Administration. 1991. 29 CFR Part 1910.1030, Occupational exposure to bloodborne pathogens: final rule. Fed. Regist. 56:64004-64182.
269. U.S. Food and Drug Administration. 1997. Protease inhibitors may increase blood glucose in HIV patients. FDA Medical Bulletin 27.
270. Van Bueren, J., R. A. Simpson, P. Jacobs, and B. D. Cookson. 1994. Survival of human immunodeficiency virus in suspension and dried onto surfaces. J. Clin. Microbiol. 32:571-574.
271. Vaqlia, A., R. Nicolin, V. Puro, G. Ippolito, C. Bettini, and F. de Lalla. 1990. Needlestick hepatitis C virus seroconversion in a surgeon. Lancet 336:1315-1316.
272. Villarejos, V. M., K. A. Visona, and A. Guitierrez. 1974. Role of saliva, urine and feces in the transmission of type B hepatitis. N. Engl. J. Med. 291: 1374-1378.
273. Vogel, W., I. Graziadei, F. Umlauft, C. Datz, F. Hackl, S. Allinger, K. Grunewald, and J. Patsch. 1996. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study. Dig. Dis. Sci. 41(Suppl. 12):81S-85S.
274. von Reyn, C. F., T. T. Gilbert, F. E. Shaw, K. C. Parsonnet, J. E. Abramson, and M. G. Smith. 1993. Absence of HIV transmission from an infected orthopedic surgeon: a 13-year look-back study. JAMA 269:1807-1811.
275. Wainwright, R. B., B. J. McMahon, L. R. Bulkow, D. B. Hall, M. A. Fitzgerald, A. P. Harpster, S. C. Hadler, A. P. Lanier, and W. L. Heyward. 1989. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA 261:2362-2366.
276. Reference deleted.
277. Reference deleted.
278. Welch, J., M. Webster, A. J. Tilzey, N. D. Noah, and J. E. Banatvala. 1989. Hepatitis B infections after gynaecological surgery. Lancet i:205-207.
279. Werman, H. A., and R. Gwinn. 1997. Seroprevalence of hepatitis B and hepatitis C among rural emergency medical care personnel. Am. J. Emerg. Med. 15:248-251.
280. Werner, B. G., and G. F. Grady. 1982. Accidental hepatitis B surface antigen positive inoculations: use of e antigen to estimate infectivity. Ann. Intern. Med. 97:367-369.
281. West, D. J. 1984. The risk of hepatitis B infection among health professionals in the United States: a review. Am. J. Med. Sci. 287:26-33.
282. West, D. J., B. Watson, J. Lichtman, T. M. Hesley, and K. Hedberg. 1994. Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy. Pediatr. Infect. Dis. J. 13:745-747.
283. Whittle, H. C., N. Maine, J. Pilkington, M. Mendy, M. Fortuin, J. Bunn, L. Allison, C. Howard, and A. Hall. 1995. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 345: 1089-1092.
284. Willy, M. E., G. L. Dhillon, N. L. Loewen, R. A. Wesley, and D. K. Henderson. 1990. Adverse exposures and universal precautions practices among a group of highly exposed health professionals. Infect. Control Hosp. Epidemiol. 11:351-356.
285. Wong, E. S., J. L. Stotka, V. M. Chinchilli, D. S. Williams, C. G. Stuart, and S. M. Markowitz. 1991. Are universal precautions effective in reducing the number of occupational exposures among health care workers? A prospective study of physicians on a medical service. JAMA 265:1123-1128.
286. Younossi, Z., and J. McHutchison. 1996. Serologic tests for HCV infection. Viral Hepatitis Rev. 2:161-173.
287. Zuckerman, J., G. Clewley, P. Griffiths, and A. Cockcroft. 1994. Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet 343:1618-1620.